Skip to main content
Fig. 2 | Molecular Medicine

Fig. 2

From: Identification and prognostic analysis of biomarkers to predict the progression of pancreatic cancer patients

Fig. 2

A Principal component analysis (PCA) of DSP data demonstrate paracancer ROIs 001–011 and cancer ROIs 001–012. B Principal component analysis (PCA) of DSP data demonstrates paracancer ROIs 005–010 and cancer ROIs 008–012. C Principal component analysis (PCA) of DSP data demonstrates paracancer ROIs 001–004 and 011 and cancer ROIs 001–007. D Volcano map display of the differentially expressed genes between paracancer ROIs 001–011 and cancer ROIs 001–012. E Volcano map display of the differentially expressed genes between paracancer ROIs 005–010 and cancer ROIs 008–012. F Volcano map display of the differentially expressed genes between paracancer ROIs 001–004 and 011 and cancer ROIs 001–07. G The mean expression level of upregulated target of LAMB3 in paracancer ROIs 005–010 and cancer ROIs 008–012. H The mean expression level of upregulated target of LAMB3, FN1, KRT17, and KRT19 in paracancer ROIs 005–010 and cancer ROIs 008–012. I The pathway network in cancer ROIs 001–012. J The pathway network in cancer ROIs 008–012

Back to article page